Studies of the capsular-like antigen of F. tularensis
土拉弗拉菌荚膜样抗原的研究
基本信息
- 批准号:8305635
- 负责人:
- 金额:$ 40.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:Active ImmunizationAnabolismAnimal ModelAntibodiesAntigensBacteriaBiologicalBiological WarfareCell Culture TechniquesCellsChemicalsElectron MicroscopyFrancisellaFrancisella tularensisGene MutationGenesHomologous GeneImmune responseImmunityInfectionInvestigationModelingMorphologyMusMutagenesisPassive ImmunizationPathogenesisPathogenicityPopulationProductionRegulationRespiratory Tract InfectionsRoleRuthenium RedSiteSolidStaining methodStainsStructureSurfaceVirulence FactorsWorkbasecapsulegenome databaseimmunogenicitymicrobialmutantprotective efficacyprotein transportsugartherapeutic developmentvaccine candidateweapons of mass destruction
项目摘要
Francisella tularensis is a class A bacterial select agent due to its extreme pathogenicity and potential use as a bioweapon. Early studies by Carlisle and Hood have indicated that F. tularensis produces a capsule-like material. Many bacteria produce capsules and the genes required to produce them encode proteins for transport, biosynthesis and regulation. Homologs of genes implicated in capsular biosynthesis are present in the Francisella genome database. Preliminary studies, using electron microscopy, indicate and confirm that a capsule-like material (CLM) surrounds F. tularensis. We can now isolate this material, free from Francisella LPS, based on chemical, chromatographic and immunochemical analysis. This material is loosely associated with the bacterial cell, is easily removed from the bacterial surface and is composed of a repeating tetrasaccharide repeat. Using transposon mutagenesis in F. tularensis Schu S4, we have identified a number of mutants with no or limited reactivity to our CLM specific antibody XE8. We have currently identified the site of insertion of 7 of these transposon mutants that have altered CLM expression that will serve as acapsular strains for the studies in this proposal. Based on these observations, we would pose the following hypotheses 1) Francisella tularensis expresses a capsular-like material that is important in pathogenesis and that we believe is a group 1 capsule; 2) Alteration of this capsule-like structure by mutations of the genes involved in biosynthesis and expression of CLM will alter pathogenicity of Francisella tularensis in cell culture models and in an animal model of respiratory infection; 3) Induction of an immune response targeted to the CLM will provide host immunity. The following specific aims will be used to resolve these hypotheses: 1) Characterization of the F. tularensis Schu S4 mutants that are defective in production of capsule-like material and 2) Characterization of the biological role of the P. tularensis Schu S4 capsule like material and 3) Study the immunogenicity and protective efficacy of passive and active immunization in murine models of Francisella infection
Francisella tularensis是A类细菌选择剂,因为其极端的致病性和潜在用作生物武器。卡莱尔(Carlisle)和胡德(Hood)的早期研究表明,tularensis会产生类似胶囊的材料。许多细菌产生胶囊,产生它们所需的基因编码蛋白质以进行运输,生物合成和调节。弗朗西斯菌基因组数据库中存在与囊囊生物合成有关的基因的同源物。使用电子显微镜的初步研究表明并确认胶囊样材料(CLM)围绕F. tularensis。现在,我们可以根据化学,色谱和免疫化学分析分离这种材料,而不受Francisella LPS的隔离。该材料与细菌细胞松散相关,很容易从细菌表面去除,并由重复的四糖重复组成。使用F. tularensis Schu S4中的转座子诱变,我们已经确定了许多对CLM特异性抗体XE8反应性无反应性的突变体。我们目前已经确定了这些转座子突变体中的7个插入部位,这些突变体改变了CLM表达,这将作为该提案中研究的交叉菌株。基于这些观察结果,我们将提出以下假设1)Francisella tularensis表达了一种类似囊状的材料,在发病机理中很重要,我们认为是1组胶囊; 2)通过在细胞培养模型和呼吸道感染的动物模型中,参与生物合成和CLM表达的基因的突变改变了这种胶囊样结构; 3)诱导针对CLM的免疫反应将提供宿主免疫。以下具体目的将用于解决这些假设:1)表征F. tularensis schu S4突变体在产生胶囊样材料时有缺陷的胶囊样材料和2)表征tularymensis schu s4囊的生物学作用,例如材料和3)研究的免疫和保护性效果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael A. Apicella其他文献
Dynamics of dendritic cell migration and the subsequent induction of protective immunity in the lung after repeated airway challenges by nontypeable <em>Haemophilus influenzae</em> outer membrane protein
- DOI:
10.1016/j.vaccine.2006.04.041 - 发表时间:
2006-07-26 - 期刊:
- 影响因子:
- 作者:
Shin-ichi Kurita;Jun Koyama;Shozaburo Onizuka;Kazushi Motomura;Hiroshi Watanabe;Kiwao Watanabe;Masachika Senba;Michael A. Apicella;Timothy F. Murphy;Horoyuki Yoneyama;Kouji Matsushima;Tsuyoshi Nagatake;Kazunori Oishi - 通讯作者:
Kazunori Oishi
Michael A. Apicella的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael A. Apicella', 18)}}的其他基金
Effect of Quorum Sensing on N. gonorrhoeae infection of human PMN's
群体感应对人中性粒细胞淋病奈瑟菌感染的影响
- 批准号:
8837569 - 财政年份:2014
- 资助金额:
$ 40.98万 - 项目类别:
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
淋病奈瑟菌群体感应和生物膜形成中的赖氨酸乙酰化
- 批准号:
8705141 - 财政年份:2014
- 资助金额:
$ 40.98万 - 项目类别:
Effect of Quorum Sensing on N. gonorrhoeae infection of human PMN's
群体感应对人中性粒细胞淋病奈瑟菌感染的影响
- 批准号:
8621355 - 财政年份:2014
- 资助金额:
$ 40.98万 - 项目类别:
Etiology of Cystic Fibrosis-Related Diabetes in a CFTR-knockout Ferret
CFTR 敲除雪貂中囊性纤维化相关糖尿病的病因学
- 批准号:
8079159 - 财政年份:2011
- 资助金额:
$ 40.98万 - 项目类别:
Studies of the capsular-like antigen of F. tularensis
土拉弗拉菌荚膜样抗原的研究
- 批准号:
7920674 - 财政年份:2010
- 资助金额:
$ 40.98万 - 项目类别:
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: LUNG
购买 JEOL JSM-7401F FESEM 的资金:肺
- 批准号:
7335218 - 财政年份:2006
- 资助金额:
$ 40.98万 - 项目类别:
Funds to acquire a JEOL JSM-7401F FESEM
购买 JEOL JSM-7401F FESEM 的资金
- 批准号:
7041487 - 财政年份:2006
- 资助金额:
$ 40.98万 - 项目类别:
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: CYSTIC FIBROSIS
获得资金购买 JEOL JSM-7401F FESEM:囊性纤维化
- 批准号:
7335219 - 财政年份:2006
- 资助金额:
$ 40.98万 - 项目类别:
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: INFECTIOUS DISEASE
获得 JEOL JSM-7401F FESEM 的资金:传染病
- 批准号:
7335217 - 财政年份:2006
- 资助金额:
$ 40.98万 - 项目类别:
FOURTEENTH INTERNATIONAL PATHOGENIC NEISSERIA CONFERENCE
第十四届国际致病性奈瑟菌会议
- 批准号:
6837459 - 财政年份:2004
- 资助金额:
$ 40.98万 - 项目类别:
相似国自然基金
组织器官衰老致退行性演变多示踪剂全身动态PET显像研究
- 批准号:91949121
- 批准年份:2019
- 资助金额:68.0 万元
- 项目类别:重大研究计划
糖脂代谢紊乱疾病灵长类动物模型构建与DNA/RNA编辑介导的基因治疗方法开发
- 批准号:91957122
- 批准年份:2019
- 资助金额:82.0 万元
- 项目类别:重大研究计划
硫胺素焦磷酸激酶缺失诱发阿尔茨海默病样多病理改变及其机制研究
- 批准号:81901081
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
代谢综合征高糖因素诱发氧化应激/炎性反应对早期前列腺增生型膀胱功能损害的作用及机制研究
- 批准号:81800671
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
维生素D在乳腺癌防治中的作用及其机制研究
- 批准号:81802642
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bordetella cell surface modification and pathogenesis
博德特氏菌细胞表面修饰和发病机制
- 批准号:
10117511 - 财政年份:2020
- 资助金额:
$ 40.98万 - 项目类别:
Bordetella cell surface modification and pathogenesis
博德特氏菌细胞表面修饰和发病机制
- 批准号:
10312117 - 财政年份:2020
- 资助金额:
$ 40.98万 - 项目类别:
Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection
预防金黄色葡萄球菌感染的新型生物结合疫苗
- 批准号:
8051590 - 财政年份:2010
- 资助金额:
$ 40.98万 - 项目类别:
Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection
预防金黄色葡萄球菌感染的新型生物结合疫苗
- 批准号:
7903554 - 财政年份:2010
- 资助金额:
$ 40.98万 - 项目类别:
Studies of the capsular-like antigen of F. tularensis
土拉弗拉菌荚膜样抗原的研究
- 批准号:
7920674 - 财政年份:2010
- 资助金额:
$ 40.98万 - 项目类别: